Bi-specific Aptamers Mediating Tumor Cell Lysis
Open Access
- 1 June 2011
- journal article
- Published by Elsevier BV
- Vol. 286 (24), 21896-21905
- https://doi.org/10.1074/jbc.m111.238261
Abstract
No abstract availableThis publication has 80 references indexed in Scilit:
- Monovalency Unleashes the Full Therapeutic Potential of the DN-30 Anti-Met AntibodyOnline Journal of Public Health Informatics, 2010
- Cancer-selective antiproliferative activity is a general property of some G-rich oligodeoxynucleotidesNucleic Acids Research, 2009
- Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumorsNature Biotechnology, 2009
- Role of polymorphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cellsCancer Immunology, Immunotherapy, 2009
- Novel bimodular DNA aptamers with guanosine quadruplexes inhibit phylogenetically diverse HIV-1 reverse transcriptasesNucleic Acids Research, 2008
- Assembling OX40 Aptamers on a Molecular Scaffold to Create a Receptor-Activating AptamerCell Chemical Biology, 2008
- Molecular assembly for high-performance bivalent nucleic acid inhibitorProceedings of the National Academy of Sciences of the United States of America, 2008
- G-quadruplex induced stabilization by 2′-deoxy-2′-fluoro-d-arabinonucleic acids (2′F-ANA)Nucleic Acids Research, 2007
- Aptamers evolved from live cells as effective molecular probes for cancer studyProceedings of the National Academy of Sciences of the United States of America, 2006
- Aptamer mediated siRNA deliveryNucleic Acids Research, 2006